In men with normal initial PSA (<3 ng/mL), the supplement was associated with a significantly reduced rate of prostate cancer, which would support the consumption of antioxidant vitamins and minerals as a method of chemoprevention of prostate cancer [296]. The gene discussed is KLK3; the disease is prostate carcinoma.